Publication | Closed Access

Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes

MedicineLiver PhysiologyCyp2d6 EnzymesImmunologyHuman Hepatic Cyp3a4PharmacotherapyHepatotoxicityMetabolismPharmacologyDrug-induced Liver Injury